nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—hematologic cancer	0.412	1	CbGaD
Gadofosveset trisodium—ALB—Imatinib—hematologic cancer	0.0772	0.383	CbGbCtD
Gadofosveset trisodium—ALB—Prednisone—hematologic cancer	0.0509	0.252	CbGbCtD
Gadofosveset trisodium—ALB—Irinotecan—hematologic cancer	0.0482	0.239	CbGbCtD
Gadofosveset trisodium—ALB—Methotrexate—hematologic cancer	0.0255	0.126	CbGbCtD
Gadofosveset trisodium—Gadoxetate—ABCC3—hematologic cancer	0.00383	1	CrCbGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—CRP—hematologic cancer	4.71e-05	0.0057	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—SOD2—hematologic cancer	4.57e-05	0.00554	CbGpPWpGaD
Gadofosveset trisodium—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.45e-05	0.0054	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL4—hematologic cancer	4.43e-05	0.00537	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CD2—hematologic cancer	4.36e-05	0.00528	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—ICAM1—hematologic cancer	4.33e-05	0.00524	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—PDGFA—hematologic cancer	4.31e-05	0.00522	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	4.26e-05	0.00516	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—GNA13—hematologic cancer	4.13e-05	0.005	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—PDGFA—hematologic cancer	4.11e-05	0.00498	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—MTHFR—hematologic cancer	4.03e-05	0.00488	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	3.96e-05	0.0048	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—JAK3—hematologic cancer	3.94e-05	0.00477	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—HGF—hematologic cancer	3.91e-05	0.00473	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—CD9—hematologic cancer	3.88e-05	0.0047	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—CCL2—hematologic cancer	3.87e-05	0.00469	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—CRP—hematologic cancer	3.83e-05	0.00464	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—HGF—hematologic cancer	3.72e-05	0.00451	CbGpPWpGaD
Gadofosveset trisodium—Asthenia—Etoposide—hematologic cancer	3.72e-05	9.93e-05	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Doxorubicin—hematologic cancer	3.72e-05	9.93e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Triamcinolone—hematologic cancer	3.71e-05	9.93e-05	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Prednisone—hematologic cancer	3.71e-05	9.92e-05	CcSEcCtD
Gadofosveset trisodium—Oedema—Prednisone—hematologic cancer	3.71e-05	9.92e-05	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Doxorubicin—hematologic cancer	3.71e-05	9.91e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Dexamethasone—hematologic cancer	3.7e-05	9.91e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Betamethasone—hematologic cancer	3.7e-05	9.91e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—CD58—hematologic cancer	3.7e-05	0.00449	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—THPO—hematologic cancer	3.7e-05	0.00449	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Irinotecan—hematologic cancer	3.7e-05	9.89e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Mitoxantrone—hematologic cancer	3.7e-05	9.89e-05	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Epirubicin—hematologic cancer	3.69e-05	9.87e-05	CcSEcCtD
Gadofosveset trisodium—Infection—Prednisone—hematologic cancer	3.69e-05	9.86e-05	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Epirubicin—hematologic cancer	3.68e-05	9.85e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.68e-05	9.84e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.68e-05	9.84e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IL3RA—hematologic cancer	3.68e-05	0.00445	CbGpPWpGaD
Gadofosveset trisodium—Fatigue—Betamethasone—hematologic cancer	3.67e-05	9.82e-05	CcSEcCtD
Gadofosveset trisodium—Fatigue—Dexamethasone—hematologic cancer	3.67e-05	9.82e-05	CcSEcCtD
Gadofosveset trisodium—Chills—Epirubicin—hematologic cancer	3.67e-05	9.8e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Etoposide—hematologic cancer	3.66e-05	9.8e-05	CcSEcCtD
Gadofosveset trisodium—Shock—Prednisone—hematologic cancer	3.65e-05	9.76e-05	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Epirubicin—hematologic cancer	3.65e-05	9.76e-05	CcSEcCtD
Gadofosveset trisodium—Pain—Betamethasone—hematologic cancer	3.64e-05	9.74e-05	CcSEcCtD
Gadofosveset trisodium—Pain—Dexamethasone—hematologic cancer	3.64e-05	9.74e-05	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Doxorubicin—hematologic cancer	3.64e-05	9.74e-05	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Prednisone—hematologic cancer	3.64e-05	9.73e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—SOD2—hematologic cancer	3.63e-05	0.0044	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	3.63e-05	0.00439	CbGpPWpGaD
Gadofosveset trisodium—Tachycardia—Prednisone—hematologic cancer	3.62e-05	9.69e-05	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Prednisone—hematologic cancer	3.61e-05	9.64e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Gemcitabine—hematologic cancer	3.6e-05	9.63e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Cisplatin—hematologic cancer	3.59e-05	9.61e-05	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Prednisone—hematologic cancer	3.59e-05	9.59e-05	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—hematologic cancer	3.58e-05	9.58e-05	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Epirubicin—hematologic cancer	3.58e-05	9.57e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Cisplatin—hematologic cancer	3.56e-05	9.53e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Cisplatin—hematologic cancer	3.56e-05	9.52e-05	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Epirubicin—hematologic cancer	3.56e-05	9.51e-05	CcSEcCtD
Gadofosveset trisodium—Erythema—Epirubicin—hematologic cancer	3.56e-05	9.51e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—PRKCG—hematologic cancer	3.55e-05	0.0043	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Etoposide—hematologic cancer	3.54e-05	9.47e-05	CcSEcCtD
Gadofosveset trisodium—Anorexia—Prednisone—hematologic cancer	3.54e-05	9.46e-05	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Doxorubicin—hematologic cancer	3.53e-05	9.45e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—ICAM1—hematologic cancer	3.52e-05	0.00427	CbGpPWpGaD
Gadofosveset trisodium—Feeling abnormal—Betamethasone—hematologic cancer	3.51e-05	9.39e-05	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Dexamethasone—hematologic cancer	3.51e-05	9.39e-05	CcSEcCtD
Gadofosveset trisodium—Flushing—Doxorubicin—hematologic cancer	3.51e-05	9.38e-05	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Doxorubicin—hematologic cancer	3.51e-05	9.38e-05	CcSEcCtD
Gadofosveset trisodium—Flatulence—Epirubicin—hematologic cancer	3.5e-05	9.37e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.49e-05	9.32e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Betamethasone—hematologic cancer	3.49e-05	9.32e-05	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Epirubicin—hematologic cancer	3.48e-05	9.31e-05	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Triamcinolone—hematologic cancer	3.46e-05	9.25e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.45e-05	0.00418	CbGpPWpGaD
Gadofosveset trisodium—Dizziness—Etoposide—hematologic cancer	3.42e-05	9.16e-05	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Epirubicin—hematologic cancer	3.42e-05	9.14e-05	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Doxorubicin—hematologic cancer	3.41e-05	9.13e-05	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—hematologic cancer	3.41e-05	9.13e-05	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Doxorubicin—hematologic cancer	3.41e-05	9.11e-05	CcSEcCtD
Gadofosveset trisodium—Chills—Doxorubicin—hematologic cancer	3.39e-05	9.07e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Betamethasone—hematologic cancer	3.39e-05	9.05e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Dexamethasone—hematologic cancer	3.39e-05	9.05e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Prednisolone—hematologic cancer	3.38e-05	9.03e-05	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Doxorubicin—hematologic cancer	3.38e-05	9.03e-05	CcSEcCtD
Gadofosveset trisodium—Asthenia—Triamcinolone—hematologic cancer	3.37e-05	9.01e-05	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Dexamethasone—hematologic cancer	3.37e-05	9.01e-05	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Betamethasone—hematologic cancer	3.37e-05	9.01e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Dexamethasone—hematologic cancer	3.37e-05	9.01e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Betamethasone—hematologic cancer	3.37e-05	9.01e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—PDGFB—hematologic cancer	3.36e-05	0.00407	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Cisplatin—hematologic cancer	3.36e-05	8.98e-05	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Epirubicin—hematologic cancer	3.35e-05	8.96e-05	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Prednisone—hematologic cancer	3.33e-05	8.91e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Triamcinolone—hematologic cancer	3.32e-05	8.89e-05	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—hematologic cancer	3.32e-05	8.87e-05	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Doxorubicin—hematologic cancer	3.31e-05	8.86e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—SRGN—hematologic cancer	3.3e-05	0.004	CbGpPWpGaD
Gadofosveset trisodium—Convulsion—Methotrexate—hematologic cancer	3.29e-05	8.8e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IFNG—hematologic cancer	3.29e-05	0.00399	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Etoposide—hematologic cancer	3.29e-05	8.8e-05	CcSEcCtD
Gadofosveset trisodium—Erythema—Doxorubicin—hematologic cancer	3.29e-05	8.8e-05	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Doxorubicin—hematologic cancer	3.29e-05	8.8e-05	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Prednisone—hematologic cancer	3.27e-05	8.74e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Etoposide—hematologic cancer	3.27e-05	8.73e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Etoposide—hematologic cancer	3.26e-05	8.72e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Etoposide—hematologic cancer	3.24e-05	8.67e-05	CcSEcCtD
Gadofosveset trisodium—Flatulence—Doxorubicin—hematologic cancer	3.24e-05	8.67e-05	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—hematologic cancer	3.24e-05	8.65e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Prednisone—hematologic cancer	3.23e-05	8.63e-05	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Doxorubicin—hematologic cancer	3.22e-05	8.62e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Prednisolone—hematologic cancer	3.22e-05	8.61e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Prednisolone—hematologic cancer	3.22e-05	8.6e-05	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.21e-05	8.59e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.21e-05	0.00388	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—hematologic cancer	3.2e-05	0.00388	CbGpPWpGaD
Gadofosveset trisodium—Fatigue—Prednisone—hematologic cancer	3.2e-05	8.56e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Prednisolone—hematologic cancer	3.2e-05	8.56e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—MTHFR—hematologic cancer	3.2e-05	0.00387	CbGpPWpGaD
Gadofosveset trisodium—Vertigo—Epirubicin—hematologic cancer	3.2e-05	8.54e-05	CcSEcCtD
Gadofosveset trisodium—Syncope—Epirubicin—hematologic cancer	3.19e-05	8.53e-05	CcSEcCtD
Gadofosveset trisodium—Constipation—Prednisone—hematologic cancer	3.17e-05	8.49e-05	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Doxorubicin—hematologic cancer	3.16e-05	8.46e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—CCL2—hematologic cancer	3.15e-05	0.00382	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MPL—hematologic cancer	3.15e-05	0.00381	CbGpPWpGaD
Gadofosveset trisodium—Palpitations—Epirubicin—hematologic cancer	3.14e-05	8.4e-05	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—hematologic cancer	3.13e-05	8.36e-05	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Epirubicin—hematologic cancer	3.13e-05	8.36e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Triamcinolone—hematologic cancer	3.11e-05	8.31e-05	CcSEcCtD
Gadofosveset trisodium—Cough—Epirubicin—hematologic cancer	3.1e-05	8.3e-05	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—hematologic cancer	3.1e-05	8.29e-05	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Doxorubicin—hematologic cancer	3.1e-05	8.29e-05	CcSEcCtD
Gadofosveset trisodium—Convulsion—Epirubicin—hematologic cancer	3.08e-05	8.24e-05	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—hematologic cancer	3.08e-05	8.24e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—RAC2—hematologic cancer	3.08e-05	0.00373	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Etoposide—hematologic cancer	3.08e-05	8.22e-05	CcSEcCtD
Gadofosveset trisodium—Hypertension—Epirubicin—hematologic cancer	3.07e-05	8.21e-05	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Prednisone—hematologic cancer	3.06e-05	8.18e-05	CcSEcCtD
Gadofosveset trisodium—Asthenia—Dexamethasone—hematologic cancer	3.06e-05	8.18e-05	CcSEcCtD
Gadofosveset trisodium—Asthenia—Betamethasone—hematologic cancer	3.06e-05	8.18e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—CRP—hematologic cancer	3.04e-05	0.00369	CbGpPWpGaD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—hematologic cancer	3.04e-05	8.13e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Prednisone—hematologic cancer	3.04e-05	8.12e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Prednisolone—hematologic cancer	3.03e-05	8.11e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—FN1—hematologic cancer	3.03e-05	0.00367	CbGpPWpGaD
Gadofosveset trisodium—Chest pain—Epirubicin—hematologic cancer	3.03e-05	8.1e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—S100A10—hematologic cancer	3.02e-05	0.00366	CbGpPWpGaD
Gadofosveset trisodium—Anxiety—Epirubicin—hematologic cancer	3.02e-05	8.07e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Dexamethasone—hematologic cancer	3.02e-05	8.06e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Betamethasone—hematologic cancer	3.02e-05	8.06e-05	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—hematologic cancer	3.01e-05	8.06e-05	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.01e-05	8.04e-05	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—hematologic cancer	3e-05	8.02e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Triamcinolone—hematologic cancer	2.99e-05	7.99e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Triamcinolone—hematologic cancer	2.96e-05	7.92e-05	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Epirubicin—hematologic cancer	2.96e-05	7.92e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Triamcinolone—hematologic cancer	2.96e-05	7.91e-05	CcSEcCtD
Gadofosveset trisodium—Vertigo—Doxorubicin—hematologic cancer	2.96e-05	7.91e-05	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—hematologic cancer	2.96e-05	7.91e-05	CcSEcCtD
Gadofosveset trisodium—Syncope—Doxorubicin—hematologic cancer	2.95e-05	7.89e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Prednisone—hematologic cancer	2.95e-05	7.88e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Triamcinolone—hematologic cancer	2.94e-05	7.87e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IL1B—hematologic cancer	2.94e-05	0.00356	CbGpPWpGaD
Gadofosveset trisodium—Body temperature increased—Prednisone—hematologic cancer	2.93e-05	7.85e-05	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Prednisone—hematologic cancer	2.93e-05	7.85e-05	CcSEcCtD
Gadofosveset trisodium—Confusional state—Epirubicin—hematologic cancer	2.93e-05	7.83e-05	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Dexamethasone—hematologic cancer	2.92e-05	7.8e-05	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Betamethasone—hematologic cancer	2.92e-05	7.8e-05	CcSEcCtD
Gadofosveset trisodium—Palpitations—Doxorubicin—hematologic cancer	2.91e-05	7.78e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—GATA2—hematologic cancer	2.91e-05	0.00352	CbGpPWpGaD
Gadofosveset trisodium—Anaphylactic shock—Epirubicin—hematologic cancer	2.9e-05	7.76e-05	CcSEcCtD
Gadofosveset trisodium—Oedema—Epirubicin—hematologic cancer	2.9e-05	7.76e-05	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—hematologic cancer	2.9e-05	7.75e-05	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Doxorubicin—hematologic cancer	2.89e-05	7.73e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—FN1—hematologic cancer	2.89e-05	0.0035	CbGpPWpGaD
Gadofosveset trisodium—Infection—Epirubicin—hematologic cancer	2.88e-05	7.71e-05	CcSEcCtD
Gadofosveset trisodium—Cough—Doxorubicin—hematologic cancer	2.87e-05	7.68e-05	CcSEcCtD
Gadofosveset trisodium—Shock—Epirubicin—hematologic cancer	2.86e-05	7.64e-05	CcSEcCtD
Gadofosveset trisodium—Convulsion—Doxorubicin—hematologic cancer	2.85e-05	7.62e-05	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Epirubicin—hematologic cancer	2.85e-05	7.61e-05	CcSEcCtD
Gadofosveset trisodium—Hypertension—Doxorubicin—hematologic cancer	2.84e-05	7.6e-05	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Epirubicin—hematologic cancer	2.83e-05	7.58e-05	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Epirubicin—hematologic cancer	2.82e-05	7.54e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Dexamethasone—hematologic cancer	2.82e-05	7.54e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Betamethasone—hematologic cancer	2.82e-05	7.54e-05	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	2.82e-05	0.00341	CbGpPWpGaD
Gadofosveset trisodium—Hyperhidrosis—Epirubicin—hematologic cancer	2.81e-05	7.5e-05	CcSEcCtD
Gadofosveset trisodium—Chest pain—Doxorubicin—hematologic cancer	2.8e-05	7.49e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—ICAM1—hematologic cancer	2.8e-05	0.00339	CbGpPWpGaD
Gadofosveset trisodium—Anxiety—Doxorubicin—hematologic cancer	2.79e-05	7.47e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Triamcinolone—hematologic cancer	2.79e-05	7.46e-05	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—hematologic cancer	2.79e-05	7.45e-05	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.78e-05	7.44e-05	CcSEcCtD
Gadofosveset trisodium—Anorexia—Epirubicin—hematologic cancer	2.77e-05	7.4e-05	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—hematologic cancer	2.77e-05	7.39e-05	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Doxorubicin—hematologic cancer	2.74e-05	7.33e-05	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Prednisone—hematologic cancer	2.73e-05	7.31e-05	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—hematologic cancer	2.73e-05	7.3e-05	CcSEcCtD
Gadofosveset trisodium—Hypotension—Epirubicin—hematologic cancer	2.71e-05	7.25e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Dexamethasone—hematologic cancer	2.71e-05	7.25e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Betamethasone—hematologic cancer	2.71e-05	7.25e-05	CcSEcCtD
Gadofosveset trisodium—Confusional state—Doxorubicin—hematologic cancer	2.71e-05	7.24e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—hematologic cancer	2.7e-05	7.21e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Dexamethasone—hematologic cancer	2.69e-05	7.19e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Betamethasone—hematologic cancer	2.69e-05	7.19e-05	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Doxorubicin—hematologic cancer	2.69e-05	7.18e-05	CcSEcCtD
Gadofosveset trisodium—Oedema—Doxorubicin—hematologic cancer	2.69e-05	7.18e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Betamethasone—hematologic cancer	2.68e-05	7.18e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Dexamethasone—hematologic cancer	2.68e-05	7.18e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—IFNG—hematologic cancer	2.68e-05	0.00325	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.68e-05	7.16e-05	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—hematologic cancer	2.67e-05	7.15e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Dexamethasone—hematologic cancer	2.67e-05	7.14e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Betamethasone—hematologic cancer	2.67e-05	7.14e-05	CcSEcCtD
Gadofosveset trisodium—Infection—Doxorubicin—hematologic cancer	2.67e-05	7.13e-05	CcSEcCtD
Gadofosveset trisodium—Asthenia—Prednisone—hematologic cancer	2.66e-05	7.12e-05	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—NUP98—hematologic cancer	2.66e-05	0.00322	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SPARC—hematologic cancer	2.66e-05	0.00322	CbGpPWpGaD
Gadofosveset trisodium—Pain—Methotrexate—hematologic cancer	2.65e-05	7.09e-05	CcSEcCtD
Gadofosveset trisodium—Shock—Doxorubicin—hematologic cancer	2.64e-05	7.07e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ATP1B1—hematologic cancer	2.64e-05	0.0032	CbGpPWpGaD
Gadofosveset trisodium—Nervous system disorder—Doxorubicin—hematologic cancer	2.63e-05	7.04e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Prednisone—hematologic cancer	2.63e-05	7.02e-05	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Doxorubicin—hematologic cancer	2.62e-05	7.01e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—S100A10—hematologic cancer	2.61e-05	0.00317	CbGpPWpGaD
Gadofosveset trisodium—Skin disorder—Doxorubicin—hematologic cancer	2.61e-05	6.98e-05	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Epirubicin—hematologic cancer	2.61e-05	6.97e-05	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Doxorubicin—hematologic cancer	2.6e-05	6.94e-05	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Epirubicin—hematologic cancer	2.59e-05	6.92e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—LCK—hematologic cancer	2.58e-05	0.00312	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—NUP214—hematologic cancer	2.56e-05	0.0031	CbGpPWpGaD
Gadofosveset trisodium—Anorexia—Doxorubicin—hematologic cancer	2.56e-05	6.85e-05	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—hematologic cancer	2.56e-05	6.83e-05	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Epirubicin—hematologic cancer	2.56e-05	6.83e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.55e-05	0.00309	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Prednisone—hematologic cancer	2.54e-05	6.79e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—hematologic cancer	2.54e-05	6.78e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Dexamethasone—hematologic cancer	2.53e-05	6.77e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Betamethasone—hematologic cancer	2.53e-05	6.77e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Epirubicin—hematologic cancer	2.52e-05	6.75e-05	CcSEcCtD
Gadofosveset trisodium—Hypotension—Doxorubicin—hematologic cancer	2.51e-05	6.71e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.51e-05	6.7e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—CCL2—hematologic cancer	2.5e-05	0.00303	CbGpPWpGaD
Gadofosveset trisodium—Fatigue—Epirubicin—hematologic cancer	2.5e-05	6.69e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—GATA1—hematologic cancer	2.5e-05	0.00303	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	2.49e-05	0.00301	CbGpPWpGaD
Gadofosveset trisodium—Pain—Epirubicin—hematologic cancer	2.48e-05	6.64e-05	CcSEcCtD
Gadofosveset trisodium—Constipation—Epirubicin—hematologic cancer	2.48e-05	6.64e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—hematologic cancer	2.46e-05	6.59e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Prednisone—hematologic cancer	2.45e-05	6.56e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	2.45e-05	0.00297	CbGpPWpGaD
Gadofosveset trisodium—Abdominal pain—Methotrexate—hematologic cancer	2.45e-05	6.56e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—hematologic cancer	2.45e-05	6.56e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.43e-05	0.00294	CbGpPWpGaD
Gadofosveset trisodium—Paraesthesia—Doxorubicin—hematologic cancer	2.41e-05	6.45e-05	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Doxorubicin—hematologic cancer	2.39e-05	6.4e-05	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Epirubicin—hematologic cancer	2.39e-05	6.4e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Folate Metabolism—IL1B—hematologic cancer	2.39e-05	0.00289	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL2—hematologic cancer	2.38e-05	0.00288	CbGpPWpGaD
Gadofosveset trisodium—Gastrointestinal pain—Epirubicin—hematologic cancer	2.37e-05	6.35e-05	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Doxorubicin—hematologic cancer	2.36e-05	6.32e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Prednisone—hematologic cancer	2.36e-05	6.31e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Prednisone—hematologic cancer	2.34e-05	6.26e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Prednisone—hematologic cancer	2.34e-05	6.25e-05	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Doxorubicin—hematologic cancer	2.33e-05	6.24e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Prednisone—hematologic cancer	2.33e-05	6.22e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.32e-05	6.2e-05	CcSEcCtD
Gadofosveset trisodium—Fatigue—Doxorubicin—hematologic cancer	2.32e-05	6.19e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Epirubicin—hematologic cancer	2.31e-05	6.17e-05	CcSEcCtD
Gadofosveset trisodium—Pain—Doxorubicin—hematologic cancer	2.3e-05	6.14e-05	CcSEcCtD
Gadofosveset trisodium—Constipation—Doxorubicin—hematologic cancer	2.3e-05	6.14e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Epirubicin—hematologic cancer	2.29e-05	6.14e-05	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Epirubicin—hematologic cancer	2.29e-05	6.14e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ANXA2—hematologic cancer	2.29e-05	0.00277	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—hematologic cancer	2.29e-05	6.11e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.28e-05	0.00277	CbGpPWpGaD
Gadofosveset trisodium—Asthenia—Methotrexate—hematologic cancer	2.23e-05	5.95e-05	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Doxorubicin—hematologic cancer	2.21e-05	5.92e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IL3—hematologic cancer	2.2e-05	0.00267	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Prednisone—hematologic cancer	2.2e-05	5.89e-05	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.2e-05	5.87e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—hematologic cancer	2.19e-05	5.87e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	2.17e-05	0.00263	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.17e-05	0.00262	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Epirubicin—hematologic cancer	2.14e-05	5.72e-05	CcSEcCtD
Gadofosveset trisodium—Urticaria—Doxorubicin—hematologic cancer	2.13e-05	5.71e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—TNF—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IFNG—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—GNA13—hematologic cancer	2.13e-05	0.00258	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SYK—hematologic cancer	2.13e-05	0.00257	CbGpPWpGaD
Gadofosveset trisodium—Abdominal pain—Doxorubicin—hematologic cancer	2.12e-05	5.68e-05	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Doxorubicin—hematologic cancer	2.12e-05	5.68e-05	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—hematologic cancer	2.12e-05	5.67e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.08e-05	0.00252	CbGpPWpGaD
Gadofosveset trisodium—Asthenia—Epirubicin—hematologic cancer	2.08e-05	5.57e-05	CcSEcCtD
Gadofosveset trisodium—Pruritus—Epirubicin—hematologic cancer	2.05e-05	5.49e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—hematologic cancer	2.05e-05	5.48e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ITGAX—hematologic cancer	2.03e-05	0.00246	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—JAK3—hematologic cancer	2.03e-05	0.00246	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CD9—hematologic cancer	2e-05	0.00242	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—F3—hematologic cancer	2e-05	0.00242	CbGpPWpGaD
Gadofosveset trisodium—Diarrhoea—Epirubicin—hematologic cancer	1.99e-05	5.31e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.98e-05	0.0024	CbGpPWpGaD
Gadofosveset trisodium—Hypersensitivity—Doxorubicin—hematologic cancer	1.98e-05	5.29e-05	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—hematologic cancer	1.97e-05	5.27e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—hematologic cancer	1.96e-05	5.23e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—hematologic cancer	1.95e-05	5.22e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—SELL—hematologic cancer	1.95e-05	0.00236	CbGpPWpGaD
Gadofosveset trisodium—Headache—Methotrexate—hematologic cancer	1.94e-05	5.2e-05	CcSEcCtD
Gadofosveset trisodium—Asthenia—Doxorubicin—hematologic cancer	1.93e-05	5.15e-05	CcSEcCtD
Gadofosveset trisodium—Dizziness—Epirubicin—hematologic cancer	1.92e-05	5.13e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	1.92e-05	0.00232	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	1.91e-05	0.00232	CbGpPWpGaD
Gadofosveset trisodium—Pruritus—Doxorubicin—hematologic cancer	1.9e-05	5.08e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IL1B—hematologic cancer	1.9e-05	0.0023	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IL3RA—hematologic cancer	1.9e-05	0.0023	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Epirubicin—hematologic cancer	1.85e-05	4.94e-05	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—hematologic cancer	1.84e-05	4.93e-05	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Doxorubicin—hematologic cancer	1.84e-05	4.91e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Epirubicin—hematologic cancer	1.83e-05	4.89e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Epirubicin—hematologic cancer	1.83e-05	4.89e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.82e-05	0.00221	CbGpPWpGaD
Gadofosveset trisodium—Headache—Epirubicin—hematologic cancer	1.82e-05	4.86e-05	CcSEcCtD
Gadofosveset trisodium—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.79e-05	0.00216	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.78e-05	0.00216	CbGpPWpGaD
Gadofosveset trisodium—Dizziness—Doxorubicin—hematologic cancer	1.78e-05	4.75e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Metabolism—FTCD—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PHYH—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GMPS—hematologic cancer	1.77e-05	0.00214	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.75e-05	0.00212	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet degranulation—VEGFA—hematologic cancer	1.73e-05	0.0021	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—TNF—hematologic cancer	1.73e-05	0.0021	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—H3F3B—hematologic cancer	1.73e-05	0.0021	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—FGR—hematologic cancer	1.73e-05	0.0021	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—HGF—hematologic cancer	1.73e-05	0.0021	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Epirubicin—hematologic cancer	1.72e-05	4.61e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Vitamin B12 Metabolism—IL6—hematologic cancer	1.72e-05	0.00208	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	1.71e-05	0.00208	CbGpPWpGaD
Gadofosveset trisodium—Vomiting—Doxorubicin—hematologic cancer	1.71e-05	4.57e-05	CcSEcCtD
Gadofosveset trisodium—Rash—Doxorubicin—hematologic cancer	1.69e-05	4.53e-05	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Doxorubicin—hematologic cancer	1.69e-05	4.52e-05	CcSEcCtD
Gadofosveset trisodium—Headache—Doxorubicin—hematologic cancer	1.68e-05	4.5e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Hemostasis—ITGAL—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MYB—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.67e-05	0.00202	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	1.65e-05	0.002	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	1.65e-05	0.002	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	1.65e-05	0.002	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.65e-05	0.00199	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SMPD3—hematologic cancer	1.61e-05	0.00196	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.61e-05	0.00195	CbGpPWpGaD
Gadofosveset trisodium—Nausea—Doxorubicin—hematologic cancer	1.6e-05	4.27e-05	CcSEcCtD
Gadofosveset trisodium—ALB—Platelet degranulation—TGFB1—hematologic cancer	1.59e-05	0.00193	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—RAC2—hematologic cancer	1.59e-05	0.00192	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.57e-05	0.0019	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	1.54e-05	0.00187	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—TP53—hematologic cancer	1.53e-05	0.00185	CbGpPWpGaD
Gadofosveset trisodium—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	1.52e-05	0.00184	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.51e-05	0.00182	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	1.49e-05	0.00181	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.47e-05	0.00178	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SH2B3—hematologic cancer	1.44e-05	0.00174	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.43e-05	0.00173	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—B3GAT1—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ASNS—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—DCK—hematologic cancer	1.41e-05	0.00171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Folate Metabolism—IL6—hematologic cancer	1.4e-05	0.0017	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	1.39e-05	0.00168	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.38e-05	0.00167	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—TNF—hematologic cancer	1.38e-05	0.00167	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SPARC—hematologic cancer	1.37e-05	0.00166	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.35e-05	0.00164	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—FN1—hematologic cancer	1.34e-05	0.00163	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HDC—hematologic cancer	1.34e-05	0.00162	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—LCK—hematologic cancer	1.33e-05	0.00161	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.31e-05	0.00159	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.3e-05	0.00158	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—H3F3A—hematologic cancer	1.3e-05	0.00158	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—GATA3—hematologic cancer	1.29e-05	0.00156	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	1.29e-05	0.00156	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—HSPA5—hematologic cancer	1.28e-05	0.00155	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.28e-05	0.00155	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PRKCZ—hematologic cancer	1.26e-05	0.00153	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.25e-05	0.00151	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CDA—hematologic cancer	1.22e-05	0.00148	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—HDAC2—hematologic cancer	1.18e-05	0.00143	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PC—hematologic cancer	1.18e-05	0.00143	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CD44—hematologic cancer	1.17e-05	0.00141	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—ITGA4—hematologic cancer	1.17e-05	0.00141	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GBA—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC35B2—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IL3—hematologic cancer	1.14e-05	0.00138	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	1.13e-05	0.00137	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IFNA1—hematologic cancer	1.13e-05	0.00137	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PTPN1—hematologic cancer	1.12e-05	0.00135	CbGpPWpGaD
Gadofosveset trisodium—ALB—Selenium Micronutrient Network—IL6—hematologic cancer	1.11e-05	0.00135	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—RASGRP1—hematologic cancer	1.1e-05	0.00133	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SYK—hematologic cancer	1.1e-05	0.00133	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	1.07e-05	0.00129	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IFNA2—hematologic cancer	1.05e-05	0.00127	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTAP—hematologic cancer	1.04e-05	0.00126	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	1.04e-05	0.00126	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—GRB2—hematologic cancer	9.88e-06	0.0012	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PDGFA—hematologic cancer	9.86e-06	0.00119	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	9.86e-06	0.00119	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.55e-06	0.00116	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—ABL1—hematologic cancer	9.5e-06	0.00115	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—FHL2—hematologic cancer	9.28e-06	0.00112	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AGRN—hematologic cancer	9.1e-06	0.0011	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—IL2—hematologic cancer	9.05e-06	0.0011	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—HGF—hematologic cancer	8.93e-06	0.00108	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CSF2—hematologic cancer	8.83e-06	0.00107	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—IDH2—hematologic cancer	8.62e-06	0.00104	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HMMR—hematologic cancer	8.62e-06	0.00104	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—JAK1—hematologic cancer	8.52e-06	0.00103	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PRKCG—hematologic cancer	8.52e-06	0.00103	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.13e-06	0.000985	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ARNTL—hematologic cancer	8.11e-06	0.000982	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.96e-06	0.000965	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IL2RA—hematologic cancer	7.96e-06	0.000964	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—SRC—hematologic cancer	7.9e-06	0.000957	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CA9—hematologic cancer	7.89e-06	0.000955	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ACP5—hematologic cancer	7.89e-06	0.000955	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NCOR2—hematologic cancer	7.78e-06	0.000943	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	7.69e-06	0.000932	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PDGFB—hematologic cancer	7.68e-06	0.000931	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CDK2—hematologic cancer	7.45e-06	0.000903	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—IDH1—hematologic cancer	7.42e-06	0.000898	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GSTO1—hematologic cancer	7.33e-06	0.000888	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—TXN—hematologic cancer	7.33e-06	0.000888	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ABCC3—hematologic cancer	7.33e-06	0.000888	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	7.28e-06	0.000882	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SPHK1—hematologic cancer	7.18e-06	0.000869	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MAPK14—hematologic cancer	7.15e-06	0.000866	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	7.06e-06	0.000855	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—FN1—hematologic cancer	6.93e-06	0.000839	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—UGT1A1—hematologic cancer	6.89e-06	0.000835	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CRABP1—hematologic cancer	6.71e-06	0.000812	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC22A1—hematologic cancer	6.71e-06	0.000812	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3CG—hematologic cancer	6.63e-06	0.000803	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ALOX5—hematologic cancer	6.54e-06	0.000792	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PTPN11—hematologic cancer	6.52e-06	0.000789	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NUP98—hematologic cancer	6.33e-06	0.000767	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—CREBBP—hematologic cancer	6.15e-06	0.000745	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ADCY7—hematologic cancer	6.14e-06	0.000744	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NCOA3—hematologic cancer	6.14e-06	0.000744	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NUP214—hematologic cancer	6.1e-06	0.000739	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.04e-06	0.000731	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.01e-06	0.000728	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ABCG2—hematologic cancer	5.98e-06	0.000724	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTR—hematologic cancer	5.98e-06	0.000724	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ENO2—hematologic cancer	5.86e-06	0.00071	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3CD—hematologic cancer	5.83e-06	0.000706	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GSTT1—hematologic cancer	5.69e-06	0.000689	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.6e-06	0.000678	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SDC1—hematologic cancer	5.56e-06	0.000673	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3R1—hematologic cancer	5.51e-06	0.000667	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—JAK2—hematologic cancer	5.35e-06	0.000648	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.32e-06	0.000645	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.31e-06	0.000643	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3CB—hematologic cancer	5.08e-06	0.000616	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.01e-06	0.000607	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.91e-06	0.000595	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CD44—hematologic cancer	4.72e-06	0.000572	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NQO1—hematologic cancer	4.72e-06	0.000572	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—IL2—hematologic cancer	4.67e-06	0.000565	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.63e-06	0.00056	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CYCS—hematologic cancer	4.47e-06	0.000542	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—HSP90AA1—hematologic cancer	4.44e-06	0.000538	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—EP300—hematologic cancer	4.19e-06	0.000507	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SRC—hematologic cancer	4.07e-06	0.000493	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4e-06	0.000484	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—VEGFA—hematologic cancer	3.97e-06	0.00048	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GSTP1—hematologic cancer	3.94e-06	0.000477	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—NRAS—hematologic cancer	3.92e-06	0.000475	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.81e-06	0.000462	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—MAPK3—hematologic cancer	3.75e-06	0.000454	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—ABCB1—hematologic cancer	3.73e-06	0.000452	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TGFB1—hematologic cancer	3.64e-06	0.000441	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GSTM1—hematologic cancer	3.62e-06	0.000439	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—NCOR1—hematologic cancer	3.62e-06	0.000439	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—KRAS—hematologic cancer	3.37e-06	0.000408	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—MTHFR—hematologic cancer	3.2e-06	0.000388	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—PIK3CA—hematologic cancer	3.1e-06	0.000375	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—TP53—hematologic cancer	3e-06	0.000363	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—HRAS—hematologic cancer	2.87e-06	0.000347	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.82e-06	0.000342	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3CG—hematologic cancer	2.69e-06	0.000326	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—AKT1—hematologic cancer	2.53e-06	0.000307	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CREBBP—hematologic cancer	2.49e-06	0.000302	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3CD—hematologic cancer	2.36e-06	0.000286	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3R1—hematologic cancer	2.23e-06	0.00027	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3CB—hematologic cancer	2.06e-06	0.00025	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PTEN—hematologic cancer	1.78e-06	0.000216	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—EP300—hematologic cancer	1.7e-06	0.000206	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—PIK3CA—hematologic cancer	1.26e-06	0.000152	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AKT1—hematologic cancer	1.03e-06	0.000124	CbGpPWpGaD
